Alison Bauerlein - 02 Jul 2026 Form 4 Insider Report for Sight Sciences, Inc. (SGHT)

Reporting relationship: Chief Operating Officer
Issuer ticker: SGHT
Reported as of: 02 Jul 2026
Net transaction value: -$129,626
SEC form: 4
Accepted by SEC: 06 Jul 2026, 19:32:43 UTC
Prior SEC filing: 19 May 2026
Source filing: View source filing
Reporting owner signature: /s/Jeremy Hayden, Attorney-in-Fact for Alison Bauerlein

Key filing fact

Alison Bauerlein filed Form 4 for Sight Sciences, Inc. (SGHT) on 06 Jul 2026.

Key facts

This page summarizes Alison Bauerlein's Form 4 filing for Sight Sciences, Inc. (SGHT).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 06 Jul 2026, 19:32.

Change

Previous filing in this sequence was filed on 19 May 2026.
Current net transaction value: -$129,626.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001596080 Primary reporting owner

Bauerlein Alison

Relationship: Chief Operating Officer
Address: C/O SIGHT SCIENCES, INC., 4040 CAMPBELL AVE., SUITE 100, MENLO PARK
Signature: /s/Jeremy Hayden, Attorney-in-Fact for Alison Bauerlein
Signature date: 06 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SGHT transaction

Common Stock

Sale

Transaction value: $129,626
Shares: -24,184
Change %: -3.5%
Price: $5.36
Shares after: 664,709
Date: 02 Jul 2026
Ownership: Direct
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 3 footnotes

Footnote F1

Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs").

Footnote F2

Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $5.19 to $5.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F3

Includes (i) 192,669 shares of Common Stock, and (ii) 472,040 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested.